ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,390,633 | -27.9% | 200,619 | -4.3% | 0.04% | -23.9% |
| Q2 2023 | $7,475,477 | +36.4% | 209,632 | -2.8% | 0.05% | +27.8% |
| Q1 2023 | $5,479,034 | -36.4% | 215,710 | +1.5% | 0.04% | -40.0% |
| Q4 2022 | $8,617,215 | +21.4% | 212,456 | -1.1% | 0.06% | +15.4% |
| Q3 2022 | $7,099,000 | -9.1% | 214,794 | -3.1% | 0.05% | -1.9% |
| Q2 2022 | $7,808,000 | -25.7% | 221,769 | -3.0% | 0.05% | -8.6% |
| Q1 2022 | $10,511,000 | -30.8% | 228,541 | -0.2% | 0.06% | -23.7% |
| Q4 2021 | $15,187,000 | +4.0% | 229,063 | -2.1% | 0.08% | -2.6% |
| Q3 2021 | $14,601,000 | -26.7% | 233,877 | -2.7% | 0.08% | +16.4% |
| Q2 2021 | $19,910,000 | +20.5% | 240,400 | -3.5% | 0.07% | +15.5% |
| Q1 2021 | $16,516,000 | -12.3% | 249,077 | +1.5% | 0.06% | -17.1% |
| Q4 2020 | $18,825,000 | +77.6% | 245,335 | -0.3% | 0.07% | +37.3% |
| Q3 2020 | $10,601,000 | -1.9% | 246,187 | -1.6% | 0.05% | -1.9% |
| Q2 2020 | $10,807,000 | +48.5% | 250,211 | -1.0% | 0.05% | +30.0% |
| Q1 2020 | $7,275,000 | -54.1% | 252,853 | +1.1% | 0.04% | -34.4% |
| Q4 2019 | $15,864,000 | +710.6% | 250,099 | +260.2% | 0.06% | +662.5% |
| Q3 2019 | $1,957,000 | +5.2% | 69,443 | -1.0% | 0.01% | +14.3% |
| Q2 2019 | $1,860,000 | +69.7% | 70,173 | +17.5% | 0.01% | +75.0% |
| Q1 2019 | $1,096,000 | +53.9% | 59,708 | +4.2% | 0.00% | +33.3% |
| Q4 2018 | $712,000 | -35.7% | 57,305 | -0.8% | 0.00% | -25.0% |
| Q3 2018 | $1,107,000 | +43.6% | 57,745 | +1.8% | 0.00% | +33.3% |
| Q2 2018 | $771,000 | +1001.4% | 56,705 | +50.9% | 0.00% | – |
| Q1 2017 | $70,000 | +29.6% | 37,574 | +8.0% | 0.00% | – |
| Q4 2016 | $54,000 | -100.0% | 34,802 | -0.3% | 0.00% | -100.0% |
| Q3 2016 | $256,464,000 | +38.4% | 34,893 | +0.2% | 0.00% | 0.0% |
| Q2 2016 | $185,349,000 | +10.3% | 34,840 | -0.0% | 0.00% | 0.0% |
| Q1 2016 | $168,000,000 | – | 34,846 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,264 | $54,392,000 | 33.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $216,228,000 | 28.00% |
| L1 Capital Pty Ltd | 296,024 | $19,629,000 | 4.93% |
| Aquilo Capital Management, LLC | 407,926 | $27,050,000 | 4.89% |
| Evolutionary Tree Capital Management, LLC | 72,948 | $4,837,000 | 2.86% |
| ACUTA CAPITAL PARTNERS, LLC | 108,000 | $7,161,000 | 2.58% |
| First Light Asset Management, LLC | 536,836 | $35,598,000 | 2.36% |
| Parkman Healthcare Partners LLC | 70,089 | $4,648,000 | 1.08% |
| Hood River Capital Management LLC | 357,082 | $23,678,000 | 0.76% |
| Vanguard Capital Wealth Advisors | 11,099 | $703,565,000 | 0.60% |